Marc Brisson

14.3k total citations
136 papers, 7.0k citations indexed

About

Marc Brisson is a scholar working on Epidemiology, Health and Surgery. According to data from OpenAlex, Marc Brisson has authored 136 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Epidemiology, 28 papers in Health and 27 papers in Surgery. Recurrent topics in Marc Brisson's work include Cervical Cancer and HPV Research (74 papers), Hepatitis B Virus Studies (48 papers) and Vaccine Coverage and Hesitancy (27 papers). Marc Brisson is often cited by papers focused on Cervical Cancer and HPV Research (74 papers), Hepatitis B Virus Studies (48 papers) and Vaccine Coverage and Hesitancy (27 papers). Marc Brisson collaborates with scholars based in Canada, United Kingdom and United States. Marc Brisson's co-authors include W. John Edmunds, Mélanie Drolet, Marie‐Claude Boily, Mark Jit, W. John Edmunds, Jean‐François Laprise, Nicolas Van de Velde, Eduardo L. Franco, Gaston De Serres and Nigel Gay and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Marc Brisson

134 papers receiving 6.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Brisson Canada	49	5.3k	1.1k	1.0k	853	831	136	7.0k
James G. Donahue United States	35	2.7k 0.5×	629 0.6×	820 0.8×	851 1.0×	1.4k 1.6×	100	5.9k
Rafael Harpaz United States	40	5.1k 1.0×	262 0.2×	1.3k 1.3×	1.2k 1.4×	1.3k 1.5×	95	6.9k
Javier Díez‐Domingo Spain	34	3.6k 0.7×	368 0.3×	540 0.5×	422 0.5×	919 1.1×	220	4.7k
Hung Fu Tseng United States	37	2.1k 0.4×	398 0.4×	602 0.6×	407 0.5×	1.2k 1.4×	158	4.3k
Shelly McNeil Canada	42	4.3k 0.8×	473 0.4×	1.7k 1.6×	201 0.2×	1.7k 2.0×	193	6.5k
Nicola P. Klein United States	52	5.5k 1.0×	1.0k 0.9×	2.9k 2.8×	185 0.2×	2.8k 3.3×	295	10.0k
Paolo Bonanni Italy	41	3.6k 0.7×	357 0.3×	2.0k 1.9×	246 0.3×	1.3k 1.5×	275	5.3k
Lina S. Sy United States	30	2.3k 0.4×	236 0.2×	669 0.6×	510 0.6×	1.1k 1.3×	124	3.6k
Aisha O. Jumaan United States	31	2.9k 0.5×	263 0.2×	519 0.5×	908 1.1×	893 1.1×	54	3.9k
Stephanie R. Bialek United States	35	3.3k 0.6×	338 0.3×	379 0.4×	656 0.8×	2.2k 2.6×	86	6.4k

Countries citing papers authored by Marc Brisson

Since Specialization

Citations

This map shows the geographic impact of Marc Brisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Brisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Brisson more than expected).

Fields of papers citing papers by Marc Brisson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Brisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Brisson. The network helps show where Marc Brisson may publish in the future.

Co-authorship network of co-authors of Marc Brisson

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Brisson. A scholar is included among the top collaborators of Marc Brisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Brisson. Marc Brisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brisson, Marc, Jean‐François Laprise, Mélanie Drolet, et al.. (2024). Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modeling. JNCI Monographs. 2024(67). 387–399.

Drolet, Mélanie, Jean‐François Laprise, Chantal Sauvageau, et al.. (2024). Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis. Canadian Medical Association Journal. 196(33). E1136–E1143.

Yang, Lily, Marie‐Claude Boily, Minttu M. Rönn, et al.. (2023). Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000–2020). PLoS Medicine. 20(1). e1004143–e1004143. 34 indexed citations

Bénard, Élodie, Mélanie Drolet, Jean‐François Laprise, et al.. (2023). Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis. The Lancet Public Health. 8(10). e788–e799. 23 indexed citations

Boily, Marie‐Claude, Ruanne V. Barnabas, Minttu M. Rönn, et al.. (2022). Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening. EClinicalMedicine. 54. 101754–101754. 15 indexed citations

Carazo, Sara, Danuta M. Skowronski, Marc Brisson, et al.. (2022). Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study. The Lancet Infectious Diseases. 23(1). 45–55. 55 indexed citations

Carazo, Sara, Denis Talbot, Nicole Boulianne, et al.. (2021). Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada. Clinical Infectious Diseases. 75(1). e805–e813. 22 indexed citations

Bolotin, Shelly, Alberto Severini, Todd F. Hatchette, et al.. (2019). Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study. Human Vaccines & Immunotherapeutics. 15(12). 2856–2864. 12 indexed citations

Whitworth, Hilary, Katherine E. Gallagher, Natasha Howard, et al.. (2019). Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials. Vaccine. 38(6). 1302–1314. 70 indexed citations

10.

Drolet, Mélanie, Shelley L. Deeks, Erich V. Kliewer, et al.. (2016). Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada. Vaccine. 34(16). 1874–1880. 15 indexed citations

11.

Brock, Patrick M., Ailsa R. Butler, Michael Pickles, et al.. (2015). Prevalence and Frequency of Heterosexual Anal Intercourse Among Young People: A Systematic Review and Meta-analysis. AIDS and Behavior. 19(7). 1338–1360. 38 indexed citations

12.

Malagón, Talía, Mélanie Drolet, Marie‐Claude Boily, Jean‐François Laprise, & Marc Brisson. (2014). Changing Inequalities in Cervical Cancer: Modeling the Impact of Vaccine Uptake, Vaccine Herd Effects, and Cervical Cancer Screening in the Post-Vaccination Era. Cancer Epidemiology Biomarkers & Prevention. 24(1). 276–285. 10 indexed citations

13.

Drolet, Mélanie, Marie‐Claude Boily, Christina Greenaway, et al.. (2013). Sociodemographic Inequalities in Sexual Activity and Cervical Cancer Screening: Implications for the Success of Human Papillomavirus Vaccination. Cancer Epidemiology Biomarkers & Prevention. 22(4). 641–652. 38 indexed citations

14.

Drolet, Mélanie, Marie‐Claude Boily, Nicolas Van de Velde, Eduardo L. Franco, & Marc Brisson. (2013). Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?. PLoS ONE. 8(6). e67072–e67072. 7 indexed citations

15.

Velde, Nicolas Van de, Marie‐Claude Boily, Mélanie Drolet, et al.. (2012). Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis. JNCI Journal of the National Cancer Institute. 104(22). 1712–1723. 110 indexed citations

16.

Drolet, Mélanie, Marc Brisson, Kenneth E. Schmader, et al.. (2010). Predictors of Postherpetic Neuralgia Among Patients With Herpes Zoster: A Prospective Study. Journal of Pain. 11(11). 1211–1221. 94 indexed citations

17.

Craig, Benjamin M., Marc Brisson, Harrell W. Chesson, Anna R. Giuliano, & Mark Jit. (2010). Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9–10, 2009. Clinical Therapeutics. 32(8). 1546–1564. 10 indexed citations

18.

Kliewer, Erich V., Alain Demers, Lawrence Elliott, et al.. (2009). Twenty-Year Trends in the Incidence and Prevalence of Diagnosed Anogenital Warts in Canada. Sexually Transmitted Diseases. 36(6). 380–386. 42 indexed citations

19.

Sénécal, Martin, Marc Brisson, Marc Lebel, et al.. (2008). Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective Community‐Based Study. Canadian Journal of Infectious Diseases and Medical Microbiology. 19(6). 397–404. 36 indexed citations

20.

Brisson, Marc. (2003). Varicella vaccination in England and Wales: cost-utility analysis. Archives of Disease in Childhood. 88(10). 862–869. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact